Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
NCT03652038
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
TD-8236
DRUG:
Placebo
Sponsor
Theravance Biopharma